Skip to content

Prospective pilot study: evaluation of a new dressing for patients treated in peritoneal dialysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN34049135
Enrollment
20
Registered
2006-10-30
Start date
2006-09-25
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure Urological and Genital Diseases Chronic renal failure

Interventions

Evaluation of dressing advantages via questionnaires

Sponsors

Gambro Industries (France)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with well healed exit site 2. Patients treated for at least three months in peritoneal dialysis irrespective of the treatment mode 3. Patients with healthy skin judged by investigator 4. Patients aged 18 years and older 5. Patients having signed a written consent (informed consent) to participate in the study

Exclusion criteria

Exclusion criteria: 1. Patients treated in hemodialysis 2. Patients with diagnosed abdominal pain not related with PD-solution 3. Peritonitis within one month prior to the study 4. Presence of exit-site, tunnel infection 5. Patients with ongoing peritonitis 6. Patients participating in other studies during the period of this study 7. Patients practising swimming 8. Patients under guardianship 9. Pregnancy, lactation

Design outcomes

Primary

MeasureTime frame
Dressing advantages are evaluated via questionnaires, which have to be filled in at specific time schedule. Comfort and safety evaluation will be performed by the patient at the end of each period of product use (end of PD Immo use and end of usual dressing use).

Secondary

MeasureTime frame
Handling is also evaluated via the patient questionnaire. The incidence of Adverse Events (AE) will be followed during the study period.

Countries

France

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026